Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gelfand, Jeffrey
NCT06422923: A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)	Recruiting	1/2	10	US	NRTX-1001, GABA-secreting interneurons	Neurona Therapeutics	Epilepsy, Temporal Lobe	07/26	07/40
MTLE, NCT05135091: FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy	Recruiting	1/2	40	US	NRTX-1001, GABA-secreting interneurons, Sham Comparator	Neurona Therapeutics, California Institute for Regenerative Medicine (CIRM)	Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis	05/25	05/26
MS-BIOME, NCT03594487: Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis	Active, not recruiting	1	30	US	FMP30 Donor Stool, Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool, Observational Control	Jeffrey Gelfand	Relapsing Remitting Multiple Sclerosis	08/24	08/24
Nazarian, Rosalynn M
No trials found